Greenbrook

Greenbrook is a healthcare provider specializing in innovative treatments for depression, including NeuroStar TMS Therapy and SPRAVATO, an FDA-approved nasal esketamine. Their mission is to offer patients a pathway to remission from depression through non-drug and non-invasive therapy options tailored to individual needs.

With a focus on accessibility, Greenbrook works directly with major insurance companies to facilitate coverage and paperwork for their patients. Their patient-centered approach ensures that both new and existing patients receive comprehensive support in their journey toward mental wellness.

Generated from the website